Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on inflammatory breast cancer.

Florence Lerebours1, Ivan Bieche, Rosette Lidereau

  • 1INSERM E0017/Oncogénétique, Centre René Huguenin, St-Cloud, France. f.lerebours@stcloud-huguenin.org

Breast Cancer Research : BCR
|March 4, 2005
PubMed
Summary

Inflammatory breast cancer (IBC) is a rare but aggressive breast cancer. Identifying its molecular drivers is crucial for developing targeted therapies and improving patient survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.

Breast cancer research : BCR·2026
Same author

Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal Cohort.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study.

British journal of cancer·2025
Same author

The role of body mass index at diagnosis in patients with inflammatory breast cancer.

Breast (Edinburgh, Scotland)·2025
Same author

Effect of Breast Surgery on Quality of Life in BRCA Mutation Carriers With Invasive Breast Cancer: A CANTO Database Study.

Clinical breast cancer·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Inflammatory breast cancer (IBC) represents the most aggressive subtype of epithelial breast cancer, characterized by rapid progression and poor prognosis.
  • Despite advancements in treatment over the last two decades, survival rates for IBC patients remain significantly lower compared to non-IBC patients.
  • The molecular underpinnings of IBC are not fully understood, hindering the development of highly specific and effective therapeutic strategies.

Purpose of the Study:

  • To review recent progress in understanding the molecular pathogenesis of inflammatory breast cancer.
  • To highlight the potential of comprehensive genomic analysis and functional assays in elucidating IBC's complex biology.
  • To emphasize the need for identifying molecular determinants to improve treatment outcomes for IBC patients.

Main Methods:

  • Review of recent scientific literature on the molecular pathogenesis of IBC.
  • Discussion of pan-genomic analysis of human IBC samples.
  • Consideration of in vitro and in vivo functional assays for IBC research.

Main Results:

  • Significant progress has been made in understanding IBC, but survival rates lag behind other breast cancers.
  • Molecular determinants are key to developing targeted treatments for IBC.
  • Pan-genomic analysis and functional assays are promising approaches for a comprehensive understanding.

Conclusions:

  • Further research into the molecular pathogenesis of IBC is essential.
  • Identifying molecular drivers of IBC can lead to more specific treatments.
  • Advanced analytical and experimental approaches hold promise for improving patient outcomes in the near future.

Related Experiment Videos